Furthermore, BDNF‐TrkB signaling also appears important for the development of inflammatory and neuropathic pain conditions, so targeting this pathway may provide a dual role by acting as an opioid adjuvant to reduce OIH and improving the chronic pain condition itself.91, 92. This evidence concerns the gene NTRK2 and Pain.